poisar

Stocks · News reference

YD Bio Announces Launch Of Two Chrono-Nutrition Supplement Formulations In Taiwan Developed With Chronic Disease Healthcare Association And Future Health Institute

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

YDES
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Yd Bio Limited

    YD Bio and EG BioMed Partner with JoiiUp to Launch AI-Driven Cancer Risk Assessment for Corporate Wellness Programs

    YD Bio and its affiliate EG BioMed have partnered with digital health provider JoiiUp to integrate an AI-driven cancer risk assessment tool into JoiiUp's JoiiSports app. The assessment, validated using over 1,200 clinical records from Taipei Medical University hospitals, analyzes demographic data and lifestyle factors across ten cancer types without requiring invasive testing. The tool will initially target corporate wellness programs through JoiiUp's network of 400+ companies, with planned expansion to healthcare institutions.

    YDESYDESW